Document is current
Any future updates will be listed below
-
Authors
Raison, Nicholas https://orcid.org/0000-0003-0496-4985
Servian, Pol
Patel, Amit
Santhirasekaram, Ainkaran
Smith, Andrew https://orcid.org/0000-0003-0352-4849
Yeung, Maidie
Lloyd, Josephine
Mannion, Ethna
Rockall, Andrea
Ahmed, Hashim
Winkler, Mathias https://orcid.org/0000-0002-2553-5816
- License Information
-
More Information
Article History
Received: 13 January 2021
Revised: 21 August 2021
Accepted: 22 October 2021
First Online: 29 November 2021
Competing interests
: HA’s research is supported by core funding from the United Kingdom’s National Institute of Health Research (NIHR) Imperial Biomedical Research Centre. HA currently receives funding from the Wellcome Trust, Medical Research Council (UK), Cancer Research UK, Prostate Cancer UK, National Institute for Health Research (UK), The Urology Foundation, BMA Foundation, Imperial Health Charity, NIHR Imperial BRC, Sonacare Inc., Trod Medical and Sophiris Biocorp for trials in prostate cancer. HA was a paid medical consultant for Sophiris Biocorp in the previous 3 years and is currently on the medical advisory board for Francis Medical. HA, is a proctor for HIFU, cryotherapy and Rezum; and is paid for training other surgeons in this procedure. No other authors declare any competing financial interests.
